title: Influence on erythropoietin levels of treatment with cisplatinum-endoxan.
abstract: Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.
authors.affiliation: Department of Obstetrics and Gynecology, University of Innsbruck, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Lechner
authors.forename: E
authors.initials: E
authors.lastname: Artner-Dworzak
authors.forename: E
authors.initials: E
authors.lastname: Sölder
authors.forename: M
authors.initials: M
authors.lastname: Sachsenmaier
authors.forename: D
authors.initials: D
authors.lastname: Kölle
authors.forename: H
authors.initials: H
authors.lastname: Moncayo
authors.forename: R
authors.initials: R
authors.lastname: Reitsamer
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged
chemical_list: D004921:Erythropoietin; D003520:Cyclophosphamide; D002945:Cisplatin